Biosimilar adalimumab on the PBS - information for health professionals and patients

Page last updated: 1 April 2021

Biosimilar brands of adalimumab (Amgevita^®, Hadlima^®, Hyrimoz^® and Idacio^®) were listed on the PBS on 1 April 2021. Information about this listing for health professionals and patients can be found on the Biosimilar Awareness Initiative webpage.